20336061|t|Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology.
20336061|a|Clinical studies suggest that agonists at peroxisome proliferator-activated receptor gamma (PPARgamma) may exert beneficial effects in patients with mild-to-moderate Alzheimer's disease (AD), but the mechanism for the potential therapeutic interest of this class of drugs has not yet been elucidated. Here, in mice overexpressing mutant human amyloid precursor protein, we found that chronic treatment with rosiglitazone, a high-affinity agonist at PPARgamma, facilitated beta-amyloid peptide (Abeta) clearance. Rosiglitazone not only reduced Abeta burden in the brain but, importantly, almost completely removed the abundant amyloid plaques observed in the hippocampus and entorhinal cortex of 13-month-old transgenic mice. In the hippocampus, neuropil threads containing phosphorylated tau, probably corresponding to dystrophic neurites, were also decreased by the drug. Rosiglitazone switched on the activated microglial phenotype, promoting its phagocytic ability, reducing the expression of proinflammatory markers and inducing factors for alternative differentiation. The decreased amyloid pathology may account for the reduction of p-tau-containing neuropil threads and for the rescue of impaired recognition and spatial memory in the transgenic mice. This study provides further insights into the mechanisms for the beneficial effect of rosiglitazone in AD patients.
20336061	0	13	Rosiglitazone	Chemical	MESH:D000077154
20336061	22	39	memory impairment	Disease	MESH:D008569
20336061	43	54	Alzheimer's	Disease	MESH:D000544
20336061	66	70	mice	Species	10090
20336061	115	118	tau	Gene	4137
20336061	172	220	peroxisome proliferator-activated receptor gamma	Gene	5468
20336061	222	231	PPARgamma	Gene	5468
20336061	265	273	patients	Species	9606
20336061	296	315	Alzheimer's disease	Disease	MESH:D000544
20336061	317	319	AD	Disease	MESH:D000544
20336061	440	444	mice	Species	10090
20336061	467	472	human	Species	9606
20336061	473	498	amyloid precursor protein	Gene	351
20336061	537	550	rosiglitazone	Chemical	MESH:D000077154
20336061	579	588	PPARgamma	Gene	5468
20336061	602	622	beta-amyloid peptide	Gene	351
20336061	624	629	Abeta	Gene	351
20336061	642	655	Rosiglitazone	Chemical	MESH:D000077154
20336061	673	678	Abeta	Gene	11820
20336061	756	771	amyloid plaques	Disease	MESH:D058225
20336061	849	853	mice	Species	10090
20336061	918	921	tau	Gene	4137
20336061	949	968	dystrophic neurites	Disease	MESH:D058225
20336061	1003	1016	Rosiglitazone	Chemical	MESH:D000077154
20336061	1126	1141	proinflammatory	Disease	
20336061	1218	1225	amyloid	Disease	MESH:C000718787
20336061	1383	1387	mice	Species	10090
20336061	1475	1488	rosiglitazone	Chemical	MESH:D000077154
20336061	1492	1494	AD	Disease	MESH:D000544
20336061	1495	1503	patients	Species	9606
20336061	Negative_Correlation	351	5468
20336061	Association	MESH:D000544	5468
20336061	Negative_Correlation	MESH:D000077154	MESH:D000544
20336061	Negative_Correlation	MESH:D000077154	4137
20336061	Positive_Correlation	MESH:D000077154	5468
20336061	Negative_Correlation	MESH:D000077154	351
20336061	Negative_Correlation	MESH:D000077154	11820
20336061	Negative_Correlation	MESH:D000077154	MESH:D058225
20336061	Negative_Correlation	MESH:D000077154	MESH:D008569

